FORTUM Ceftazidime 1 g / 0.035 oz for Injection

FORTUM Ceftazidime 1 g / 0.035 oz for Injection

$10.00

FORTUM® Ceftazidime 1 g / 0.035 oz. Ceftazidime for Injection for dogs, cats, and reptiles.
Ceftazidime injection is a 3rd generation cephalosporin that has the potential to be useful in treating gram-negative bacterial infections with respects to susceptible Enterobacteriaceae as well as Pseudomonas aeruginosa in dogs, cats, and reptiles.

  • Description
  • Additional information
  • Doses and Uses
  • Shipping & Payment
  • Reviews (0)

Description

Buy online FORTUM Ceftazidime 1 g / 0.035 oz. Ceftazidime for Injection for dogs, cats, and reptiles.
Forms of realease FORTUM:
– 500 mg;
– 1 g;
– 2 g.

Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. FORTUM is a sterile, dry-powdered mixture of ceftazidime pentahydrate and sodium carbonate. The sodium carbonate at a concentration of 118 mg/g of ceftazidime activity has been admixed to facilitate dissolution. The total sodium content of the mixture is approximately 54 mg (2.3 mEq)/g of Ceftazidime activity.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of FORTUM and other antibacterial drugs, FORTUM should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Solutions of FORTUM range in color from light yellow to amber, depending on the diluent and volume used. The pH of freshly constituted solutions usually ranges from 5 to 8.

Ceftazidime injection is a 3rd generation cephalosporin that has the potential to be useful in treating gram-negative bacterial infections with respects to susceptible Enterobacteriaceae as well as Pseudomonas aeruginosa in dogs, cats, and reptiles.

INDICATIONS:
FORTUM is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:

  • Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Haemophilus influenzae, including ampicillin-resistant strains; Klebsiella spp.; Enterobacter spp.; Proteus mirabilis; Escherichia coli; Serratia spp.; Citrobacter spp.; Streptococcus pneumoniae; and Staphylococcus aureus (methicillin-susceptible strains).
  • Skin and Skin-Structure Infections caused by Pseudomonas aeruginosa; Klebsiella spp.; Escherichia coli; Proteus spp., including Proteus mirabilis and indole-positive Proteus; Enterobacter spp.; Serratia spp.; Staphylococcus aureus (methicillin-susceptible strains); and Streptococcus pyogenes (group A beta-hemolytic streptococci).
  • Urinary Tract Infections, both complicated and uncomplicated, caused by Pseudomonas aeruginosa; Enterobacter spp.; Proteus spp., including Proteus mirabilis and indolepositive Proteus; Klebsiella spp.; and Escherichia coli.
  • Bacterial Septicemia caused by Pseudomonas aeruginosa, Klebsiella spp., Haemophilus influenzae, Escherichia coli, Serratia spp., Streptococcus pneumoniae, and Staphylococcus aureus (methicillin-susceptible strains).
  • Bone and Joint Infections caused by Pseudomonas aeruginosa, Klebsiella spp., Enterobacter spp., and Staphylococcus aureus (methicillin-susceptible strains).
  • Gynecologic Infections, including endometritis, pelvic cellulitis, and other infections of the female genital tract caused by Escherichia coli.
  • Intra-abdominal Infections, including peritonitis caused by Escherichia coli, Klebsiella spp., and Staphylococcus aureus (methicillin-susceptible strains) and polymicrobial infections caused by aerobic and anaerobic organisms and Bacteroides spp. (many strains of Bacteroides fragilis are resistant).
  • Central Nervous System Infections, including meningitis, caused by Haemophilus influenzae and Neisseria meningitidis. Ceftazidime has also been used successfully in a limited number of cases of meningitis due to Pseudomonas aeruginosa and Streptococcus pneumoniae.
  • FORTUM may be used alone in cases of confirmed or suspected sepsis. Ceftazidime has been used successfully in clinical trials as empiric therapy in cases where various concomitant therapies with other antibacterial drugs have been used.
  • FORTUM may also be used concomitantly with other antibacterial drugs, such as aminoglycosides, vancomycin, and clindamycin; in severe and life-threatening infections; and in the immunocompromised patient. When such concomitant treatment is appropriate, prescribing information in the labeling for the other antibacterial drugs should be followed. The dose depends on the severity of the infection and the patient’s condition.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of FORTUM and other antibacterial drugs, FORTUM should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

SIDE EFFECTS:

  • Swelling, redness, or pain at the injection site may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
  • Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
  • Tell your doctor right away if you have any serious side effects, including: easy bruising/bleeding, unusual tiredness, shaking, muscle spasms, uncontrollable movements, mental/mood changes (such as confusion), seizures, signs of kidney problems (such as change in the amount of urine), signs of liver problems (such as nausea/vomiting that doesn’t stop, loss of appetite, stomach/abdominal pain, yellowing eyes/skin, dark urine).
  • This medication may rarely cause a severe intestinal condition (Clostridium difficile-associated diarrhea) due to a type of resistant bacteria. This condition may occur during treatment or weeks to months after treatment has stopped. Tell your doctor right away if you develop: diarrhea that doesn’t stop, abdominal or stomach pain/cramping, blood/mucus in your stool.
  • Do not use anti-diarrhea products or narcotic pain medications if you have any of these symptoms because these products may make them worse.
  • Use of this medication for prolonged or repeated periods may result in oral thrush or a new yeast infection. Contact your doctor if you notice white patches in your mouth, a change in vaginal discharge, or other new symptoms.
  • A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
  • This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

PRECAUTIONS:

  • Before using ceftazidime, tell your doctor or pharmacist if you are allergic to it; or to other antibiotics (such as penicillins, other cephalosporins); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
  • Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney disease, stomach/intestinal diseases (such as colitis).
  • Ceftazidime may cause live bacterial vaccines (such as typhoid vaccine) to not work as well. Do not have any immunizations/vaccinations while using this medication unless your doctor tells you to.

KEEP
BEFORE OPENING: Store at 20º to 25°C (68º to 77ºF) (See USP Controlled Room Temperature). Protect from light.
AFTER OPENING: Properly reconstituted solution of Ceftazidime are stable for 12 hours at room temperature or 3 days if refrigerated (5°C). Slight yellowing does not affect potency.

Additional information

Weight 100 g
Forms of release

Powders

Volume / Weight

1 g, 2 g

Packing

Glass bottle

Manufacturer

GlaxoSmithKline Manufacturing (Italy)

Country/Region of Manufacture

Italy

Ceftazidime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as Cephalosporin antibiotics. It works by stopping the growth of bacteria.

HOW to USE Ceftazidime Vial

This medication is given by injection into a muscle or vein as directed by your doctor, usually every 8 to 12 hours. The dosage is based on your medical condition and response to treatment.

If you are using this medication at home, learn all preparation and usage instructions from your health care professional. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.

If you are using the frozen pre-mixed solution, thaw the bag at room temperature or in the refrigerator. If the bag is thawed in the refrigerator, let it sit at room temperature at least 1 hour before using. Do not thaw by putting in a water bath or microwaving. After thawing, shake well and squeeze the bag to check for leaks. Discard solution if the bag leaks. Do not re-freeze the solution after thawing.

For the best effect, use this antibiotic at evenly spaced times. To help you remember, use this medication at the same time(s) every day.

FOR INTRAVENOUS or INTRAMUSCULAR USE:

Each vial contains Ceftazidime Pentahydrate equivalent to 1 gram of Ceftazidime and 118 mg of Sodium Carbonate (Sodium content is approximately 54 mg or 2.3 mEq per gram of Ceftazidime activity).

IMPORTANT: This vial is under reduced pressure. Addition of diluent generates a positive pressure. Before reconstituting, see Instructions for Reconstitution. To prepare IM solution, add 3 mL of an approved diluent. To prepare IV solution, add 10 mL of Sterile Water for Injection.

USUAL DOSAGE: See prescribing information for dosage and administration.

Continue to use this medication for the full time prescribed, even if symptoms disappear after a few days. Stopping the medication too early may result in a return of the infection.

Tell your doctor if your condition lasts or gets worse.

STANDART SHIPPING WORLDWIDE
WEIGHT (kg) COST ($US) ESTIMATED

DELIVERY TIME

TRACKING
0 - 0.199 6.50 15 - 21 working days Available
0.200 - 0.250 8.00 15 - 21 working days Available
0.251 - 0.500 14.00 15 - 21 working days Available
0.501 - 1.000 20.00 15 - 21 working days Available
1.000 - 2.000 25.00 15 - 21 working days Available

PAYMENT

  • We accept Visa, MasterCard via AdvCash & Payeer (there are problems with the possibility).
  • We accept SEPA, BACS.
  • We accept RIA.
  • We accept Cryptocurrency.
  • PayPal.

Depending on the method of payment, additional Fees / VAT are charged.

And also there is a system of bonuses that you can spend on your next purchases.

Reviews

There are no reviews yet.


Only logged in customers who have purchased this product may leave a review.

You've just added this product to the cart: